http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2390289-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f176518209caeedcb0dd8be4ee27525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4960a8840db73502e4d95c961ddf9c0c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6911 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate | 2007-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23ef113bb93d1aa9f85854abaa7000e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d83f01705fadcd6b9082a3c27de54a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d92272a43e2217681500f5a8ffcec0ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6df06dfc76b5d65ea8b61b57690da8bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db2a411079e25ee16c5c2feda4c31381 |
| publicationDate | 2012-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2390289-T3 |
| titleOfInvention | Synthetic platelets |
| abstract | A synthetic platelet substitute that interacts with platelets and the (sub) endothelium, which comprises: a. a carrier molecule comprising lipid particles with a crosslinked surface mesh, in which the lipid particles comprise: an internal lipid particle of pharmaceutically acceptable departic forming lipids; hydrophilic polymer chains attached to the surface of the lipid particle, the hydrophilic polymer chains being non-toxic linear chain and comprising a cross-linkable terminal group at the free ends thereof; and crosslinking groups that join the end groups of the hydrophilic polymer chains to form the crosslinked surface mesh; and b. at least one receptor molecule bound to the surface of the carrier molecule, wherein the receptor molecule is a peptide selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 , SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEC ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, analogs thereof having a sequence identity of 90% and modified peptides thereof having an insertion of a Cys residue and / or a spectrophotometrically traceable amino acid and / or a poly-Gly marker consisting of from 1 to 5 residues of Gly. |
| priorityDate | 2006-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.